THE avian pancreas is a pale yellow-red organ situated on the dorsal mesentery between the ascending and descending loops of the duodenum. It has three distinct lobes, the 
parenchymatous bridges. The splenic lobe extends cranially from either the ventral or dorsal lobe (King and McLelland 1984) .
The pancreas has endocrine and exocrine functions. The exocrine component of the pancreas is composed by a tubulo-acinar glandular complex responsible for the secretion of amylase, lipase and proteinases including tripsin and chymotrypsin. This glandular secretion drains into the distal part of the ascending duodenum and close to the bile ducts, by one, two or three pancreatic ducts (King and McLelland 1984) .
The endocrine component of the pancreas is integrated by the islets of Langerhans. In avian species there are three types of islets: dark, light and mixed islets. The dark islets contain Alpha and Delta cells, while the light islets contain Beta and Delta cells. Mixed islets contain all three types of cells. One type of Alpha cells produces the polypeptide glucagon, a hormone that plays a more prominent role than insulin in carbohydrate metabolism by increasing the concentrations of free fatty acids and raising the plasma glucose. It also plays an important role in fat metabolism. The Beta cells produce the well-known hormone insulin. The levels of this hormone in the avian pancreas are considerably lower than those in mammals. Insulin also plays a minor role in carbohydrate metabolism, but its main role is as an anabolic hormone. The Delta cells secrete somatostatin, a hormone with a possible role in regulating the secretion of insulin and glucagon (Epple and Stetson 1980) .
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Several disorders affecting the avian pancreas have been previously described. For a comprehensive review of the different disorders the reader is referred to Lothrop 1996 , Hoefer 1997 and Keymer and Samour 2000 . Pancreatic atrophy has been reported in the budgerigar (Beach 1962 , Hasholt 1972 and in a blue and yellow macaw (Ara ararauna) (Quesenberry and Liu 1986) . To the knowledge of the authors, pancreatic atrophy has not been documented in birds of prey. This report describes a case of pancreatic atrophy in a peregrine falcon (Falco peregrinus). presumably Strigea falconis, ova present in the faeces. The falcon was given 25mg/kg praziquantel orally (Droncit, Bayer, UK) and was discharged the same day with a second dose to be given one week later. The falcon was presented for a follow up visit nine days later.
The owner had noticed that despite eating normally, the falcon was loosing weight. The bodyweight had decreased to 828g. The owner stressed that the faeces were semisolid, dark to pale brown in colour and abnormally large in appearance. Routine clinical examination revealed marked dyspnoea when stressed. Parasitological analysis of the faeces proved negative for the presence of endoparasites. Haematological results revealed a moderate high white cell count (14.8 x10 9 /l, normal range 3.8 -11.5 x10 9 /l), with heterophilia (10.95 x10 9 /l, normal range 2.6 -5.85 x10 9 /l), and a slight monocytosis (1.77 x10 9 /l, normal range 0 -0.8 x10 9 /l). An endoscopy examination carried out the same day revealed mild air sacculitis The histopathology report included the presence of numerous small and a few large granulomas in the parenchyma of the pancreas (Fig. 2) . In addition, there was acute degeneration of the islets of Langerhans, vacuolisation and atrophy of the acinar cells, mild interstitial fibrosis and marked heterophil and macrophage infiltration of surrounding connective tissue (Fig 2) . The liver showed marked haemosiderosis of Kupffer cells and hepatocytes and activation of Kupffer cells. The histopathology report concluded pancreatic atrophy with reactive pancreatitis.
In the present case, the clinical signs at the time of admission and the observations made during the endoscopy examination did not provide conclusive evidence of a pancreatic disorder. It is possible that the pancreas was already undergoing morphological changes, both in size and in colour at the time of the endoscopy examination. Whether these changes were too subtle to be noticed or that the changes became more pronounced, and therefore more evident, after the examination cannot be ascertained. 
